Search Results - "Rheumatology (Oxford, England)"
-
1
The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies
Published in Rheumatology (Oxford, England) (01-11-2017)“…The aim was to review the worldwide incidence and prevalence of SLE and variation with age, sex, ethnicity and time. A systematic search of MEDLINE and EMBASE…”
Get full text
Journal Article -
2
A systematic review and meta-analysis of infection risk with small molecule JAK inhibitors in rheumatoid arthritis
Published in Rheumatology (Oxford, England) (01-10-2019)“…Abstract Objectives To evaluate the risk of serious infection (SI) and herpes zoster (HZ) in rheumatoid arthritis patients receiving JAK inhibitors. Methods We…”
Get full text
Journal Article -
3
Herpes zoster following BNT162b2 mRNA COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: a case series
Published in Rheumatology (Oxford, England) (09-10-2021)“…Objectives As global vaccination campaigns against COVID-19 disease commence, vaccine safety needs to be closely assessed. The safety profile of mRNA-based…”
Get full text
Journal Article -
4
JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis
Published in Rheumatology (Oxford, England) (01-02-2019)“…Abstract Janus kinase (JAK)/signal transducers and activators of transcription (STATs) are a group of molecules associated with one of the major pathways…”
Get full text
Journal Article -
5
-
6
Clinical significance of Janus Kinase inhibitor selectivity
Published in Rheumatology (Oxford, England) (01-06-2019)“…Cytokines are key drivers of inflammation in RA, and anti-cytokine therapy has improved the outcome of RA. Janus Kinases (JAK) are intracellular tyrosine…”
Get full text
Journal Article -
7
Tofacitinib for refractory interstitial lung diseases in anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis
Published in Rheumatology (Oxford, England) (01-12-2018)“…Abstract Objective We aimed to determine the outcome of combination therapy with tofacitinib (TOF) in a case series of refractory rapidly progressive…”
Get full text
Journal Article -
8
The frequency and outcome of lupus nephritis: results from an international inception cohort study
Published in Rheumatology (Oxford, England) (01-02-2016)“…To determine nephritis outcomes in a prospective multi-ethnic/racial SLE inception cohort. Patients in the Systemic Lupus International Collaborating Clinics…”
Get full text
Journal Article -
9
European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis—the SHARE initiative
Published in Rheumatology (Oxford, England) (01-09-2019)“…Abstract Objectives IgA vasculitis (IgAV, formerly known as Henoch–Schönlein purpura) is the most common cause of systemic vasculitis in childhood. To date,…”
Get full text
Journal Article -
10
The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
Published in Rheumatology (Oxford, England) (01-01-2018)Get full text
Journal Article -
11
Osteoarthritis: the genesis of pain
Published in Rheumatology (Oxford, England) (01-05-2018)“…Abstract OA is a painful joint disease that predominantly affects the elderly. Pain is the primary symptom of OA, and it can present as either intermittent or…”
Get full text
Journal Article -
12
Osteosarcopenia: where osteoporosis and sarcopenia collide
Published in Rheumatology (Oxford, England) (01-02-2021)“…Abstract The coexistence of osteoporosis and sarcopenia has been recently considered in some groups as a syndrome termed ‘osteosarcopenia’. Osteoporosis…”
Get full text
Journal Article Web Resource -
13
The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease
Published in Rheumatology (Oxford, England) (01-04-2017)“…GCA and PMR are conditions of older persons that frequently overlap. The traditional concept of GCA has focused on cranial symptoms such as headache and visual…”
Get full text
Journal Article -
14
Mechanisms of immune-related adverse events during the treatment of cancer with immune checkpoint inhibitors
Published in Rheumatology (Oxford, England) (01-12-2019)“…Abstract Immune checkpoint inhibitors are novel biologic agents to treat cancer by inhibiting the regulatory interactions that limit T cell cytotoxicity to…”
Get full text
Journal Article -
15
British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis
Published in Rheumatology (Oxford, England) (01-03-2020)Get full text
Journal Article -
16
Lupus nephritis: clinical presentations and outcomes in the 21st century
Published in Rheumatology (Oxford, England) (05-12-2020)“…Abstract Lupus nephritis (LN) is a frequent and severe manifestation of SLE. Along the decades, the epidemiology of LN and its clinical presentation have been…”
Get full text
Journal Article -
17
-
18
Incidence and severeness of COVID-19 hospitalization in patients with inflammatory rheumatic disease: a nationwide cohort study from Denmark
Published in Rheumatology (Oxford, England) (09-10-2021)“…Abstract Objectives To estimate the incidence of COVID-19 hospitalization in patients with inflammatory rheumatic disease (IRD); in patients with RA treated…”
Get full text
Journal Article -
19
What drives osteoarthritis?-synovial versus subchondral bone pathology
Published in Rheumatology (Oxford, England) (01-09-2017)“…Subchondral bone and the synovium play an important role in the initiation and progression of OA. MRI often permits an early detection of synovial hypertrophy…”
Get full text
Journal Article -
20
Intravenous cyclophosphamide vs rituximab for the treatment of early diffuse scleroderma lung disease: open label, randomized, controlled trial
Published in Rheumatology (Oxford, England) (01-12-2018)“…Abstract Objectives SSc is characterized by fibrotic changes in the skin and lung, and the mainstay of treatment has been CYC. B cell involvement suggests that…”
Get full text
Journal Article